Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries.

Competing Interests: Conflict of interest: C. Martin reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Chiesi and Zambon. Conflict of interest: P-R. Burgel reports consulting fees from AstraZeneca, Chiesi, GSK, Insmed, Vertex and Zambon, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Pfizer and Novartis.